Actively Recruiting
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
Led by Zhaoshen Li · Updated on 2025-02-11
100
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
Sponsors
Z
Zhaoshen Li
Lead Sponsor
O
Oriental Hepatobiliary Surgery Hospital Affiliated to Naval Military Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to test in patients with cystic tumor of pancreas. The main questions it aims to answer are: Screening of molecular diagnostic markers for pancreatic cystic tumors by cfDNA methylation sequencing of pancreatic cystic fluid and proteomic assays to distinguish benign from malignant and mucinous/non-mucinous, correlate with pathological features, and find molecular features associated with the degree of malignancy. Participants will Provide post-operative cyst fluid specimens.
CONDITIONS
Official Title
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects are 60; 18 years old, regardless of gender
- Preoperative imaging examination (EUS, CT, MRI) diagnosed cystic mass of pancreas and suspected cystic tumor
- Subjects voluntarily accepted radical resection of pancreatic cystic tumors
- Subjects or family members voluntarily sign the informed consent form for clinical research
You will not qualify if you...
- The excised sample does not contain cystic components, or the cystic fluid cannot be collected
- Receive tumor-related treatment (radiotherapy, chemotherapy, immunotherapy, etc.) before operation
- Receive antibiotic treatment within 1 week before operation
- Subjects refused to accept radical resection of pancreatic cystic tumor, or had any situation that they could not accept radical resection of pancreatic cystic tumor
- The subjects or their families refused to sign the informed consent form for clinical research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433
Actively Recruiting
Research Team
K
Kaixuan Wang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here